TD Asset Management
MEDP icon

TD Asset Management’s Medpace MEDP Stock Holding History

TD Asset Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$135M Sell
217,396
-46,476
-18% -$27.2M 0.12% 153
2026
Q2 		$140M Buy
263,872
+130,819
+98% +$60.4M 0.12% 146
2026
Q1 		$63.9M Buy
133,053
+81,513
+158% +$41.7M 0.05% 259
2025
Q4 		$28.9M Sell
51,540
-76,607
-60% -$43.5M 0.02% 433
2025
Q3 		$65.9M Sell
128,147
-329,498
-72% -$144M 0.05% 265
2025
Q2 		$144M Buy
457,645
+61,764
+16% +$18.5M 0.12% 152
2025
Q1 		$121M Sell
395,881
-68,080
-15% -$22.9M 0.11% 168
2024
Q4 		$154M Sell
463,961
-39,113
-8% -$13.3M 0.14% 147
2024
Q3 		$167M Sell
503,074
-8,194
-2% -$3.11M 0.15% 140
2024
Q2 		$211M Sell
511,268
-62,881
-11% -$24.9M 0.2% 118
2024
Q1 		$232M Buy
574,149
+107,108
+23% +$37.7M 0.22% 108
2023
Q4 		$143M Buy
467,041
+308,816
+195% +$83.4M 0.14% 138
2023
Q3 		$38.3M Sell
158,225
-13,505
-8% -$3.45M 0.05% 301
2023
Q2 		$41.2M Sell
171,730
-32,886
-16% -$6.83M 0.05% 306
2023
Q1 		$38.5M Sell
204,616
-31,132
-13% -$6.44M 0.05% 306
2022
Q4 		$50.1M Sell
235,748
-49,489
-17% -$9.9M 0.06% 255
2022
Q3 		$44.5M Buy
285,237
+19,442
+7% +$3.1M 0.06% 269
2022
Q2 		$39.8M Buy
265,795
+16,829
+7% +$2.44M 0.05% 301
2022
Q1 		$40.7M Buy
248,966
+9,071
+4% +$1.5M 0.04% 326
2021
Q4 		$52.2M Sell
239,895
-2,019
-0.8% -$423K 0.04% 318
2021
Q3 		$45.8M Sell
241,914
-1,014
-0.4% -$185K 0.05% 299
2021
Q2 		$42.7M Buy
242,928
+40,815
+20% +$7.04M 0.04% 320
2021
Q1 		$33.2M Buy
+202,113
New +$30.9M 0.04% 360
2020
Q3 		– Sell
-5,400
Closed -$502K – 1378
2020
Q2 		$502K Sell
5,400
-7,400
-58% -$630K ﹤0.01% 1213
2020
Q1 		$939K Buy
+12,800
New +$1.11M ﹤0.01% 1016

Other funds holding MEDP

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

TD Asset Management's MEDP Position: Q3 2026 in Review

TD Asset Management reduced its Medpace (MEDP) stake by 18% in Q3 2026, selling an estimated $27.2M and leaving 217,396 shares worth $135M. The position accounts for 0.12% of the portfolio, ranked #153.

TD Asset Management first reported a position in MEDP in Q1 2020 and has held it in 25 quarters since. The position peaked at $232M in Q1 2024. 602 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • TD Asset Management held 217,396 shares of Medpace worth $135M as of Q3 2026.
  • TD Asset Management sold 46,476 Medpace shares in Q3 2026, an estimated $27.2M.
  • Medpace made up 0.12% of TD Asset Management's portfolio in Q3 2026, its #153 holding.
  • TD Asset Management first reported a position in Medpace in Q1 2020 and has held it in 25 quarters since.
  • TD Asset Management's Medpace position peaked at $232M in Q1 2024.
  • 602 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on TD Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.